human
rhinoviru
hrv
infect
respons
common
coldlik
ill
hrv
common
viru
trigger
acut
exacerb
asthma
chronic
obstruct
pulmonari
diseas
primari
site
hrv
infect
replic
upper
lower
airway
human
airway
epitheli
cell
thought
hrvinduc
chang
epitheli
biolog
contribut
symptom
support
hrvinfect
human
airway
cell
grown
either
undifferenti
cell
submers
cultur
cell
differenti
cultur
airliquid
interfac
ali
releas
proinflammatori
chemokin
cytokin
sever
also
detect
airway
secret
hrv
infect
hrv
infect
also
trigger
epitheli
induct
rang
potenti
host
antivir
molecul
may
limit
viral
replic
much
understand
hrv
replic
induc
host
antivir
respons
base
studi
use
nonairway
cell
line
eg
hela
cell
infer
studi
picornavirus
hrv
replic
requir
viru
entri
cell
genom
releas
viral
polyprotein
translat
posit
sens
rna
genom
viral
rna
polymeras
subsequ
gener
neg
strand
copi
hrv
genom
neg
strand
serv
templat
replic
posit
strand
genom
packag
viru
capsid
thu
rv
replic
doublestrand
rna
dsrna
gener
accord
dogma
regul
level
viral
replic
also
recogn
pattern
recognit
receptor
mediat
induct
proinflammatori
antivir
respons
viral
releas
infect
cell
occur
via
cell
lysi
although
gener
held
innat
immun
play
key
role
regul
outcom
hrv
infect
thought
immun
cell
also
play
import
role
viral
clearanc
human
airway
epitheli
cell
cultur
reproduc
vivo
epitheli
morpholog
surviv
month
permit
experi
much
longer
durat
could
achiev
submers
cultur
expos
highli
differenti
cultur
human
bronchial
epitheli
cell
hbe
vari
initi
infecti
dose
hrv
monitor
respons
h
show
contrari
exist
dogma
hbe
clear
hrv
infect
without
need
immun
cell
addit
observ
level
drna
assess
quantif
neg
strand
templat
rna
correl
tempor
quantit
maxim
intracellular
viral
genom
load
mark
contrast
maxim
level
type
type
iii
interferon
ifn
well
host
defens
molecul
relat
peak
neg
strand
templat
level
rather
vari
depend
initi
infecti
dose
hrv
use
hbe
obtain
proteas
digest
dissect
airway
main
stem
bronchu
gener
previous
describ
store
aliquot
liquid
nitrogen
use
n
valu
experiment
data
repres
use
cell
differ
individu
donor
hbe
cell
cultur
flask
costar
corn
inc
corn
ny
bronchial
epitheli
growth
medium
begm
lonza
walkersvil
md
supplement
fb
h
life
technolog
burlington
ontario
canada
cell
fed
everi
h
begm
without
fb
confluenc
cell
lift
seed
cell
per
insert
onto
pore
transwel
insert
costar
coat
bovin
collagen
type
iiii
advanc
biomatrix
san
diego
ca
cultur
begm
h
begm
remov
hbe
cultur
use
basolater
pneumacultali
differenti
medium
contain
supplement
hydrocortison
heparin
stemcel
technolog
vancouv
bc
canada
well
fluconazol
sigmaaldrich
oakvil
ontario
canada
penicillinstreptomycin
life
technolog
cell
fed
basolater
everi
h
begin
day
seed
cell
wash
apic
per
week
pb
remov
excess
mucu
cultur
use
experi
week
transwel
seed
stock
propag
cell
purifi
sucros
densiti
centrifug
describ
purifi
dialys
use
kda
membran
mm
media
h
remov
sucros
replicationdefici
gener
exposur
ultraviolet
light
min
describ
ali
cultur
infect
apic
dilut
mm
h
cell
wash
apic
time
pb
remov
nonintern
maintain
feed
basal
pneumacult
everi
h
shed
collect
appropri
time
point
rins
apic
surfac
ali
cultur
pb
intracellular
rna
isol
assess
intracellular
hrv
level
ali
cultur
fix
paraformaldehyd
alfa
aesar
heysham
uk
min
room
temperatur
cell
block
permeabil
bsa
ng
normal
rabbit
serum
normal
mous
serum
pb
h
rins
pb
cell
stain
mous
sigma
bsa
pb
overnight
cell
wash
time
pb
stain
thermofish
scientif
waltham
bsa
pb
h
room
temperatur
cell
wash
time
pb
reblock
mous
serum
pb
h
mous
antidsrna
antibodi
scicon
szriak
hungari
label
label
kit
thermofish
preabsorb
bsa
normal
mous
serum
pb
h
ad
cell
overnight
cell
wash
time
pb
nuclei
subsequ
stain
dapi
thermofish
min
insert
mount
use
fluorsav
emd
millipor
imag
leica
tc
reson
scan
confoc
microscop
leica
wetzlar
germani
leica
lasaf
softwar
hbe
fix
neutral
buffer
formalin
embed
paraffin
section
thick
onto
superfrost
plu
slide
alcian
blue
hematoxylin
stain
perform
deparaffin
two
chang
xylen
rehydr
grade
ethanol
solut
etoh
alcian
blue
sigma
acet
acid
solut
ad
min
rins
water
min
hematoxylin
gill
ii
leica
biosystem
stain
perform
min
rins
warm
tap
water
min
slide
dehydr
revers
grade
ethanol
solut
etoh
clear
two
chang
xylen
appli
coverslip
permount
thermofisch
total
cellular
rna
isol
nucleospin
rna
kit
machereynagel
gmbh
co
duren
germani
includ
homogen
lysat
oncolumn
dnase
digest
elut
rnasednas
free
water
rna
concentr
puriti
determin
nanodrop
spectrophotomet
viperin
mrna
express
assess
realtim
rtpcr
use
specif
primer
taqman
probe
gene
mrna
synthet
firststrand
cdna
use
gener
standard
curv
permit
absolut
quantif
data
express
femtogram
calcul
standard
curv
data
convert
copi
number
posit
sens
genom
rna
detect
limit
rtpcr
system
correspond
total
copi
number
viral
rna
apic
wash
sampl
isol
qiaamp
viral
rna
mini
kit
qiagen
mississauga
ontario
canada
subject
quantit
rtpcr
use
primer
probe
direct
region
assay
use
chimer
primer
revers
transcript
contain
nonvir
sequenc
end
specif
sequenc
target
neg
strand
nonvir
sequenc
use
primer
select
amplifi
neg
strand
specif
cdna
pcr
stage
valid
assay
select
use
synthet
hplcpurifi
neg
posit
strand
oligonucleotid
sequenc
span
sequenc
use
assay
confirm
primer
system
neg
strand
show
posit
signal
use
excess
posit
strand
also
detect
serial
dilut
neg
strand
affect
presenc
multifold
excess
posit
strand
sequenc
one
microgram
rna
revers
transcrib
maxima
revers
transcriptas
rnase
h
activ
invitrogen
carlsbad
ca
chimer
primer
tabl
nonvir
sequenc
taken
within
escherichia
coli
genom
blast
search
confirm
lack
homolog
within
rhinoviru
genom
remov
potenti
carri
rna
cdna
rnase
treat
rnase
cocktail
invitrogen
cdna
purifi
use
qiaquick
pcr
purif
kit
qiagen
hilden
germani
realtim
pcr
carri
specif
forward
primer
probe
direct
within
region
nonvir
revers
primer
synthet
firststrand
cdna
standard
use
quantifi
amount
templat
present
absolut
valu
use
determin
copi
number
measur
elisa
use
match
antibodi
pair
peprotech
rocki
hill
nj
elisa
r
system
minneapoli
usa
hbe
cultur
airliquid
interfac
ali
week
use
pneumacultali
differenti
medium
show
morpholog
resembl
bronchial
epithelium
vivo
pseudostratifi
columnar
structur
contain
welldefin
goblet
cell
numer
ciliat
cell
fig
cultur
show
increas
height
greater
cilia
coverag
compar
typic
cultur
shown
highli
differenti
cultur
hbe
show
evid
overt
toxic
point
infect
histolog
evalu
cultur
expos
either
medium
studi
h
infect
period
fig
show
obviou
differ
either
two
treatment
compar
basal
week
cultur
fig
hbe
differ
lung
donor
infect
dose
rang
tissu
cultureinfect
dose
intracellular
shed
level
hrv
genom
rna
monitor
time
rtpcr
express
total
copi
number
either
cell
insert
total
amount
releas
time
peak
level
intracellular
genom
rna
vari
occur
later
lower
infecti
dose
fig
despit
peak
copi
number
genom
hrv
observ
similar
regardless
initi
infecti
dose
interestingli
h
infect
hrv
viral
genom
within
cell
declin
undetect
level
infecti
dose
except
detect
residu
burden
limit
singl
donor
hrv
shed
infect
hbe
occur
exclus
apic
surfac
detect
viru
basolater
medium
initi
infecti
dose
time
cours
peak
level
hrv
shed
mirror
intracellular
viru
suggest
steadyst
intracellular
viru
rate
shed
fig
shed
viru
level
return
undetect
h
postinfect
except
singl
donor
infect
confirm
viru
measur
rtpcr
reflect
infecti
virion
hrv
apic
wash
cell
infect
initi
dose
measur
viral
titer
assay
show
pattern
viral
load
shown
understand
relationship
dsrna
hrv
replic
innat
antivir
immun
initi
perform
immunofluoresc
confoc
microscopi
dens
ciliat
cultur
fig
monoclon
antibodi
direct
dsrna
use
cell
expos
fluoresc
signal
observ
noninfect
hbe
hbe
expos
replicationdefici
shown
cell
infect
perinuclear
dsrna
stain
observ
h
post
infect
fig
interestingli
stain
restrict
ciliat
cell
fig
determin
percentag
total
cell
posit
dsrna
cell
donor
use
three
differ
field
view
donor
assess
reticul
use
defin
field
view
percentag
total
cell
field
base
dapi
nuclear
stain
posit
dsrna
record
use
method
averag
total
cell
show
posit
stain
dsrna
next
develop
assay
specif
quantifi
neg
strand
templat
rna
express
total
copi
number
index
level
dsrna
tempor
pattern
neg
strand
templat
product
initi
infecti
dose
close
mirror
level
posit
strand
genom
fig
seen
posit
strand
similar
peak
intracellular
level
neg
strand
rna
observ
regardless
initi
dose
viru
use
infect
howev
case
level
neg
strand
approxim
lower
posit
strand
genom
use
neg
strand
copi
number
data
assess
relationship
dsrna
level
product
number
molecul
cultur
contrast
close
associ
level
neg
strand
templat
genom
posit
strand
relationship
observ
product
ifn
level
intracellular
mrna
tempor
relat
neg
strand
templat
fig
show
quantit
relationship
instead
level
ifn
mrna
declin
initi
infecti
dose
use
level
secret
protein
releas
dominantli
apic
surfac
show
similar
pattern
although
depend
infecti
dose
hrv
peak
protein
secret
occur
later
maxim
mrna
level
fig
level
neg
strand
alreadi
maxim
h
follow
infect
perform
separ
experi
period
h
infect
dose
neg
strand
templat
detect
h
infect
increas
peak
level
h
fig
interestingli
increas
express
mrna
observ
h
alreadi
compar
maxim
level
observ
fig
express
mrna
protein
secret
predominantli
basolater
medium
chemokin
show
similar
tempor
quantit
pattern
ifn
clear
relationship
level
induct
initi
infecti
dose
fig
previous
shown
role
viperin
host
defens
hrv
infect
also
examin
mrna
express
molecul
fig
highest
initi
infecti
dose
peak
express
viperin
slightli
delay
rel
ifn
moreov
depend
infecti
dose
less
clear
compar
viperin
express
observ
initi
infecti
dose
except
reduct
express
lower
dose
less
mark
gener
host
defens
molecul
examin
depend
upon
viral
replic
sinc
exposur
hbe
render
replic
defici
exposur
uv
light
induc
epitheli
express
molecul
studi
shown
hela
cervic
carcinoma
cell
line
invalu
develop
vaccin
polioviru
eas
infect
hela
cell
picornaviru
famili
member
led
frequent
use
cell
studi
picornaviru
replic
physiolog
relev
studi
hrv
replic
must
question
howev
sinc
hrv
select
infect
airway
hrv
infect
studi
vivo
demonstr
epitheli
cell
natur
site
hrv
infect
replic
use
human
airway
epitheli
cell
line
subsequ
primari
hbe
grown
submers
cultur
ali
provid
import
insight
inflammatori
innat
immun
respons
hrv
infect
hbe
submers
cultur
suit
howev
studi
complet
hrv
replic
cycl
confluent
cultur
maintain
extend
period
initi
ali
cultur
hbe
use
cell
grown
bronchial
epitheli
differenti
medium
week
yield
cultur
multilay
express
cilia
reproduc
vivo
pseudostratifi
columnar
morpholog
contrast
ali
cultur
grown
pneumacult
medium
recapitul
vivo
morpholog
moreov
cultur
maintain
month
ali
permit
current
studi
examin
hrv
replic
cycl
respons
vari
initi
infecti
dose
hrv
although
well
differenti
cultur
human
airway
epitheli
cell
use
studi
kinet
respons
infect
respiratori
syncyti
viru
knowledg
first
use
cell
extend
kinet
studi
respons
hrv
infect
data
clearli
show
similar
peak
intracellular
shed
level
hrv
genom
rna
observ
regardless
initi
infecti
dose
viru
although
peak
viral
replic
delay
lower
infecti
dose
whether
peak
level
intracellular
shed
viru
observ
infecti
dose
repres
maxim
viral
replic
support
cell
unclear
given
initi
infecti
materi
remov
cell
contain
level
hrv
distinguish
dose
appli
shown
would
appear
virion
taken
cell
thu
unclear
delay
replic
observ
lower
dose
one
could
specul
fewer
cell
initi
infect
lower
dose
take
longer
cell
support
replic
infect
regardless
major
observ
current
studi
highli
differenti
hbe
clear
infect
h
infect
regardless
initi
infecti
dose
use
reflect
intracellular
shed
viru
level
note
gener
time
cours
shed
viru
cultur
resembl
observ
nasal
secret
follow
experiment
infect
normal
volunt
overal
data
indic
epitheli
antivir
respons
adequ
clear
infect
recruit
inflammatori
immun
cell
airway
mucosa
vivo
may
contribut
symptom
cell
essenti
viru
clearanc
gener
neg
strand
templat
prerequisit
transcript
new
genom
rna
strand
process
transcrib
neg
strand
genom
rna
lead
format
dsrna
examin
format
dsrna
use
two
complementari
approach
immunofluoresc
stain
valid
antibodi
dsrna
show
perinuclear
stain
dsrna
h
post
infect
time
maxim
intracellular
viru
load
perinuclear
local
consist
concept
hrv
replic
membran
fragment
deriv
endoplasm
reticulum
golgi
use
marker
cilia
observ
hrv
replic
restrict
ciliat
cell
agre
recent
report
hrva
hrvc
strain
select
infect
ciliat
cell
assess
total
cell
posit
dsrna
stain
consist
observ
focal
patchi
infect
observ
bronchial
biopsi
report
hbe
grown
submers
cultur
infect
regardless
initi
infecti
dose
hrv
use
knowledg
prior
quantit
assess
level
dsrna
achiev
airway
epitheli
cell
infect
hrv
examin
absolut
copi
number
neg
strand
mean
quantifi
dsrna
prior
studi
singl
strand
genom
virus
shown
convent
rtpcr
target
neg
strand
provid
strandspecif
phenomenon
fals
prime
yield
signal
even
absenc
primer
revers
transcript
studi
use
singl
strand
gener
vitro
transcript
plasmid
shown
rtpcr
neg
strand
specif
presenc
excess
posit
strand
therefor
modifi
previous
publish
strategi
primer
revers
transcript
contain
nonvir
sequenc
end
specif
sequenc
target
neg
strand
nonvir
sequenc
use
primer
select
amplifi
neg
strand
specif
cdna
pcr
stage
techniqu
show
similar
level
neg
strand
thu
presum
dsrna
achiev
regardless
initi
infecti
dose
albeit
vari
timecours
impli
defin
level
neg
strand
requir
optim
replic
genom
rna
concept
put
forward
polioviru
genom
translat
function
templat
neg
strand
synthesi
also
hold
true
hrv
would
suggest
defin
level
viru
polyprotein
strand
translat
infect
order
support
optim
viral
replic
given
copi
number
neg
strand
lower
posit
strand
transcript
posit
strand
templat
must
highli
effici
data
differ
previou
report
ratio
posit
strand
per
neg
strand
cell
infect
polioviru
assess
use
rnase
protect
assay
differ
may
due
specif
natur
cell
host
cell
type
use
prior
polioviru
studi
never
defin
differ
virus
sensit
specif
method
use
dsrna
gener
viral
replic
recogn
pattern
recognit
receptor
prr
induc
innat
immun
respons
studi
report
vari
role
dsrna
receptor
tolllik
retino
acid
induc
genei
melanoma
differenti
associ
induc
epitheli
respons
hrv
infect
type
type
iii
ifn
produc
epitheli
cell
respons
viral
infect
recent
studi
indic
type
iii
ifn
particularli
domin
ifn
produc
human
airway
epitheli
cell
respons
hrv
infect
confirm
observ
highli
differenti
epitheli
cell
show
induct
mrna
protein
consider
higher
level
observ
interestingli
howev
despit
rel
constant
level
neg
strand
templat
gener
initi
infecti
dose
level
mrna
protein
type
type
iii
ifn
decreas
markedli
initi
infecti
dose
hrv
decreas
interestingli
level
ifn
produc
bear
time
hrv
clearanc
impli
neither
type
ifn
control
viral
clearanc
ifn
gener
cell
expos
hrv
render
replic
defici
exposur
uv
light
shown
sinc
hrv
treat
way
still
engag
receptor
impli
induct
ifn
requir
viral
replic
engag
receptor
infecti
dose
kinet
quantiti
ifn
induct
mirror
neg
strand
templat
thu
degre
induct
ifn
simpli
regul
level
dsrna
reflect
level
neg
strand
impli
factor
gener
replic
cycl
must
play
role
ident
factor
unknown
singlestrand
rna
replic
intermedi
compon
viral
genom
may
contribut
induct
mrna
protein
close
mirror
induct
ifn
term
kinet
quantiti
sinc
previous
report
induct
mediat
via
ifn
signal
may
induct
ifn
occur
via
share
pathway
interest
differ
vectori
releas
ifn
mainli
apic
mainli
basolater
also
observ
epitheli
mediat
shown
point
reason
differ
unknown
interestingli
although
viperin
mrna
level
highest
infect
level
rel
constant
three
lower
infecti
dose
persist
mrna
express
two
gene
lower
infecti
dose
despit
profound
declin
ifn
level
suggest
induct
mediat
type
type
iii
ifn
although
viperin
usual
refer
member
group
ifnstimul
gene
isg
preced
isg
induc
independ
ifn
ifnindepend
induct
occur
via
direct
viral
induct
key
transcript
factor
particularli
member
interferon
regulatori
factor
irf
famili
thu
cell
defici
type
type
iii
ifn
receptor
still
show
induct
multipl
isg
respons
influenza
infect
similarli
previous
show
viperin
induc
independ
ifn
signal
via
mediat
mechan
consist
previous
shown
robust
induct
hrvinfect
human
airway
epitheli
cell
demonstr
induct
hrv
depend
upon
transcript
control
although
textbook
frequent
state
hrv
virion
escap
cell
via
lysi
base
studi
hela
cell
known
year
howev
hrv
infect
vivo
caus
overt
epitheli
cytotox
consist
observ
overt
cell
death
observ
highli
differenti
cultur
hbe
upon
infect
hrv
intact
epithelium
still
observ
h
hrv
infect
fig
histolog
integr
differ
compar
cell
expos
medium
h
epithelium
prior
infect
fig
rule
death
shed
small
percentag
cell
occur
infect
epithelium
either
gener
replac
cell
els
adjac
cell
expand
maintain
intact
epithelium
term
altern
mean
hrv
escap
epitheli
cell
preced
hrv
enteroviru
speci
leav
cell
type
via
phosphatidylserin
rich
membran
vesicl
properti
either
exosom
autophagosom
like
vesicl
addit
studi
requir
howev
evalu
occur
hrv
infect
highli
differenti
hbe
current
studi
use
member
hrva
genet
group
rhinovirus
use
gain
cell
entri
use
repres
larg
number
hrva
strain
also
use
commonli
use
vivo
experiment
infect
nonetheless
must
avoid
gener
data
strain
hrv
addit
studi
requir
determin
hrva
strain
use
low
densiti
lipoprotein
receptor
hrvc
strain
requir
cadherin
relat
famili
member
gain
cell
entri
show
pattern
viru
clearanc
epitheli
integr
neg
strand
templat
express
antivir
gene
express
observ
also
interest
determin
respons
second
consecut
infect
either
hrv
strain
differ
one
show
alter
respons
summari
demonstr
infect
subset
ciliat
cell
highli
differenti
cultur
hbe
infect
clear
without
need
immun
cell
time
clearanc
depend
level
ifn
regardless
initi
infecti
dose
use
rel
constant
level
genom
neg
strand
rna
gener
albeit
vari
kinet
copi
number
negativestrand
rna
lower
number
posit
genom
strand
although
rel
constant
level
neg
strand
gener
regardless
initi
infecti
dose
level
type
type
iii
ifn
vari
depend
upon
initi
infecti
dose
impli
factor
level
dsrna
regul
ifn
induct
pattern
viperin
express
suggest
may
gener
ifnindepend
manner
infect
data
challeng
number
wide
held
paradigm
gener
earlier
studi
hela
cell
emphas
import
appropri
cell
context
perform
experi
use
hrv
infect
